bovnews7h
Trevi Therapeutics Inc (TRVI) Stock Rated Outperform by Leerink Partners
Notable insider trades include GOOD JENNIFER L, President & CEO at Trevi Therapeutics Inc (TRVI), who sold 40277 shares on Sep 05 ’24, at $3.11 each, totaling $0.13 million. On May 29 ’24, SCIASCIA ...
FiercePharma4h
In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines
With an expanded recommendation from the Center for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...
Leerink Partnrs Issues Positive Estimate for Opthea Earnings
Analysts at Leerink Partnrs lifted their FY2025 EPS estimates for shares of Opthea in a report released on Tuesday, October ...
bovnews9h
Voyager Therapeutics Inc (VYGR) Stock: A Deeper Look at Its True Potential
On Tuesday, Voyager Therapeutics Inc (VYGR) stock saw a decline, ending the day at $6.19 which represents a decrease of $-1.47 or -19.19% from the prior close of $7.66. The stock opened at $6.93 and ...
Leerink Partners' Affiliate, MEDACorp, Launches the Center for Pharmacoeconomics to Evaluate the Societal Impact of Healthcare Treatments
Leerink Partners' affiliate, MEDACorp, announced today the launch of a new division, the Center for Pharmacoeconomics (CPE), which will be dedicated to advancing the understanding of the societal ...
Leerink Partnrs Has Negative Outlook of Biohaven Q3 Earnings
Research analysts at Leerink Partnrs cut their Q3 2024 earnings per share (EPS) estimates for Biohaven in a report released ...
Nasdaq29d
Leerink Partners Initiates Coverage of Voyager Therapeutics (VYGR) with Outperform Recommendation
Fintel reports that on October 16, 2024, Leerink Partners initiated coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a Outperform recommendation. As of September 25, 2024, the average one ...
Mind Medicine assumed with an Outperform at Leerink
Leerink assumed coverage of Mind Medicine with an Outperform rating and $20 price target The firm likes the emerging ...